Evaluation of Cell-Penetrating Peptide Delivery of Antisense Oligonucleotides for Therapeutic Efficacy in Spinal Muscular Atrophy. (2019)
Attributed to:
Peptide conjugated oligonucleotides for a phase I/IIa clinical trial in Spinal Muscular Atrophy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-4939-9670-4_13
PubMed Identifier: 31410800
Publication URI: http://europepmc.org/abstract/MED/31410800
Type: Journal Article/Review
Volume: 2036
Parent Publication: Methods in molecular biology (Clifton, N.J.)
ISSN: 1064-3745